International Programs News, Speeches, and Publications

Connect with us:  Follow @FDA_Global on Twitter

The News, Speeches, and Publications page contains current information about international program activities at home and abroad.

News

• FDA Achieves Key Milestone, Finalizes Framework That Will Resume Shellfish Trade with Europe for the First Time in 10 Years (Press Release, September 2020)
• FDA holds meetings with EC and EMA to strengthen medical products cooperation (June 2020)
• First regulatory workshop on COVID-19 facilitates global collaboration on vaccine development, European Medicines Agency Press Release (March 2020)
• Food-borne Illnesses Cost US $110 Billion Per Year in Low- and Middle-Income Countries (The World Bank press release (October 2018)
• Increasing oversight of API manufacturing through international collaboration (European Medicines Agency press release (April 2018) 
• FDA takes unprecedented step toward more efficient global pharmaceutical manufacturing inspections (October 2017) 
• Mutual Recognition promises new framework for pharmaceutical inspections for United States and European Union (March 2017) 

Speeches 

• Presentation by Bruce Ross for the APHA's 2020 Virtual Annual Meeting, HHS's Global Health Workforce – On the Front Lines of Health Diplomacy During the Time of COVID-19 (October 2020)
• Testimony by Mark Abdoo, Associate Commissioner for Global Policy and Strategy before the U.S.-China Economic & Security Review Commission (July 2019)
• Remarks by Mary Lou Valdez to the North American Food Safety and Quality 2019 Conference (June 2019) 
• Remarks by Mark Abdoo at the Opening Plenary Session, Drug Information Association (DIA) China Annual Meeting (May 2019)
• Remarks by Mark Abdoo at the AFDO 2018 Conference, International and Government Relations Committee Meeting (June 2018)

Publications  

• Equivalence: Using a Trade Mechanism to Ensure Broader Consumer Choice and Open New Markets for Molluscan Shellfish (FDA Voices, September 23, 2020)
• From a Global Perspective - Occasional thought pieces on international topics from FDA experts across the agency
• Ensuring Patient Safety and Drug Manufacturing Quality Through Partnership with European Union Regulators, by Anna Abram, FDA Deputy Commissioner for Policy, Planning, Legislation and Analysis and Mark Abdoo, FDA’s Associate Commissioner for the Office of Global Policy and Strategy (FDA Voices, July 2019)
• FDA’s Global Efforts to Protect Patients and Consumers from Unsafe Products, by Anna Abram, FDA Deputy Commissioner for Policy, Planning, Legislation and Analysis and Mark Abdoo, FDA’s Associate Commissioner for the Office of Global Policy and Strategy (FDA Voices, November 2018)
• The Safe Food Imperative: Accelerating Progress in Low- and Middle-Income Countries, The World Bank (October 2018)
• FDA Collaborates to Promote Safety, Quality in Clinical Trials Done in India (FDA Voices, July 2017)
• FDA in India: Championing a Culture of Quality (FDA Voices, March 2017)